The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Viking Therapeutics Inc. (VKTX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.16, or 1.01%, to $15.94. The Viking Therapeutics Inc. has recorded 15,579 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Viking Therapeutics to Participate at Upcoming Investor Conferences.
Viking Therapeutics Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $15.78 and fluctuated between $16.36 as its day high and $15.46 as its day low. The current market capitalization of Viking Therapeutics Inc. is $1.45B. A total of 2.35 million shares were traded on the day, compared to an average of 2.32M shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, VKTX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 43 BUYs and 34 SELLs from insiders. Insiders purchased 1,963,236 shares during that period but sold 1,764,159.
In the most recent transaction, Rowland Charles A Jr sold 40,000 shares of VKTX for 25.00 per share on May 16. After the transaction, the Director now owns 30,000 company shares. In a previous transaction on May 16, MACARTNEY LAWSON sold 16,000 shares at 24.00 per share. VKTX shares that Director owns now total 47,965.
Among the insiders who sold shares, Lian Brian disposed of 45,000 shares on May 01 at a per-share price of $22.45. This resulted in the President & CEO holding 2,197,963 shares of VKTX after the transaction. In another insider transaction, MACARTNEY LAWSON sold 16,000 shares at $22.00 per share on Apr 24. Company shares held by the Director now total 47,965.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for VKTX in the last 3 months, the mean price target is $33.80 with high estimates of $40.00 and low estimates of $28.00. In terms of 52-week highs and lows, VKTX has a high of $25.72 and a low of $2.53.
As of this writing, VKTX has an earnings estimate of -$0.22 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of -$0.18 per share and a lower estimate of -$0.24. The company reported an EPS of -$0.25 in the last quarter, which was -4.20% lower than expectations of -$0.24.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VKTX’s latest balance sheet shows that the firm has $202.10M in Cash & Short Term Investments as of fiscal 2021. There were $29.00k in debt and $8.78M in liabilities at the time. Its Book Value Per Share was $3.90, while its Total Shareholder’s Equity was $201.88M.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VKTX is Buy with a score of 4.90.